Browsing by Author "Yoshino, Takayuki"
Now showing items 1-6 of 6
-
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
Tabernero Caturla, Josep; Grothey, Axel; Van Cutsem, Eric; Yaeger, Rona; Wasan, Harpreet; Yoshino, Takayuki (American Society of Clinical Oncology, 2021-02-01) -
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Yoshino, Takayuki; Di Bartolomeo, Maria; Raghav, Kanwal; Masuishi, Toshiki; Loupakis, Fotios; Kawakami, Hisato; Elez, Elena (Nature Portfolio, 2023-06-07) -
FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer
Dasari, Arvind; Sobrero, Alberto; Yao, James; Schelman, William; Yang, Zhao; Tabernero Caturla, Josep; Yoshino, Takayuki (Future Science Group, 2021-08) -
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses
Lenz, Heinz-Josef; Argilés Martinez, Guillem; Falcone, Alfredo; Limón, María Luisa; Yoshino, Takayuki; Lonardi, Sara (Elsevier, 2019-12) -
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
Kim, Tae Won; Yong, Wei Peng; Shiu, Kai-Keen; Vittrup, Benny; Elez Fernandez, Mª Elena; Yoshino, Takayuki; André, Thierry (Wiley, 2023-03) -
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC
Kopetz, Scott; Grothey, Axel; Van Cutsem, Eric; Yaeger, Rona; Wasan, Harpreet; Tabernero Caturla, Josep; Yoshino, Takayuki (Elsevier, 2022-06)